Where does Simpson Biotech Co., Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Simpson Biotech Co., Ltd. ranks #37,554 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Simpson Biotech Co., Ltd. hold?

Simpson Biotech Co., Ltd. holds 7 US utility patents granted between 2015 and 2022, spanning 8 technology areas.

What is Simpson Biotech Co., Ltd.'s Innovation Score?

Simpson Biotech Co., Ltd. has an Innovation Score of 28.3 out of 100 (27th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Simpson Biotech Co., Ltd. focus on?

Simpson Biotech Co., Ltd.'s top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 5 patents, ranking #3,434 of 6,058 assignees active in that subclass. Grants appear in 8 CPC subclasses total.

Is Simpson Biotech Co., Ltd.'s patent grant rate increasing or decreasing?

Simpson Biotech Co., Ltd.'s recent grant velocity is -83% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Simpson Biotech Co., Ltd.'s patents?

Simpson Biotech Co., Ltd.'s patents average 7.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Simpson Biotech Co., Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Simpson Biotech Co., Ltd.

USPTO PatentsView assignee record - 7 granted patents across 8 technology areas, recorded in grant years 2015–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Simpson ranks #37,554 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 8 technology areas.

#37,554
of 49,997 US assignees by volume: 27th percentile
by Innovation Score (28.3/100): 7.4
avg claims per patent: -83%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R37554 · Foreign Corporation #37,554 · 7 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-SPARSE · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 7 grants
LOWER-Q #37,554/49,997
PHOTO-FINISH Silmach
CPC-NARROW A61P · 8 areas
INNOV-THIN 28.3/100
CLAIMS-SPARSE 7.4 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -83% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Silmach (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Simpson’s 28.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 7.2 pts (25%) Velocity 6.7 pts (24%) Breadth 10.0 pts (35%) Claim depth 4.5 pts (16%)

Qualcomm Incorporated · highest

85
Simpson Biotech · this assignee

28
3D Lighting… · lowest

7

What this shows Simpson's Innovation Score is 28.3/100 (27th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Simpson?

Each dot is one of Simpson’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Simpson’s own 7.4 claims/patent is at or below the 9.6 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Simpson vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Simpson's grants concentrate

Simpson Biotech Co., Ltd. is a focused PatentsView assignee: 8 CPC subclasses with 71.4% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2015 (2 grants) versus a trough of 1 in 2016. By volume, Simpson sits between Silmach and Sinopec Engineering Incorporation.

Simpson's three-year grant acceleration

Simpson Biotech Co., Ltd. shows 1 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Silmach

7
Silver Cross (IP)

7
Simplicity Works…

7
Simplivia Healthc…

7
SIMU

7
Simur

7
Singularity

7
Sinopec Engineeri…

7
Simpson Biotech ◀

7

What this shows Simpson holds 7 patents at rank #37,423, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Simpson

By rank, the assignees closest to #37,423 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Simpson's primary technology class.

Simpson's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

28 27th percentile higher than 27% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Simpson Biotech Co., Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	28.6%
2016	1	14.3%
2017	2	28.6%
2018	1	14.3%
2022	1	14.3%

Which technologies does Simpson Biotech Co., Ltd. patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 5

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 4

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 2

C07K - Peptides 2

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 1

H01S - Devices Using THE Process OF Light Amplification BY Stimulated Emission OF Radiation [LASER] TO Amplify OR Generate LIGHT; Devices Using Stimulated Emission OF Electromagnetic Radiation IN Wave Ranges Other Than Optical 1

A61Q - Specific USE OF Cosmetics OR Similar Toiletry Preparations 1

C07D - Heterocyclic Compounds 1

Top 8 of 8 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Simpson Biotech Co., Ltd.'s patent record in context - here's where to go next.

Simpson Biotech Co., Ltd.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 71.4% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #37,554 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Simpson Biotech Co., Ltd. against Silmach, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 28.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.